Abstract:Objective To analyze the causes and influences of secondary percutaneous coronary intervention (PCI) for patients with ST-segment elevation myocardial infarction (STEMI) combined with heart failure with reduced ejection fraction (HFrEF) in the context of clinical features and biomarkers, and to provide direction for future intervention strategies. Methods Statistical analysis of the reasons for underwent secondary PCI, and multiple logistic regression analysis of the influencing factors of underwent secondary PCI in patients with STEMI complicated by HFrEF. The acceptance of secondary PCI was subjected to statistical analysis to determine its reasons, and the influencing factors of secondary PCI in patients with STEMI and HFrEF were analyzed by multivariate logistic regression. Results The incidence of undergoing secondary PCI was 18.9%. The reasons for undergoing secondary PCI were as follows: stent restenosis (32.1%), new coronary artery disease (26.8%), multivessel disease (21.4%), arrhythmia (8.9%), myocardial ischemia (7.1%), and thrombosis (3.6%). Incomplete revascularization, diabetes duration > 5 years, admission Gensini score > 100, and postoperative angiopoietin II were identified as independent risk factors for undergoing secondary PCI in patients with STEMI complicated by HFrEF, while postoperative kallikrein-1 was an independent protective factor (P < 0.01 or P < 0.05). Conclusion There are many factors that can affect the undergoing secondary PCI,stent restenosis is the most common cause of underwent secondary PCI.